Canakinumab treatment in a young girl with refractory chronic recurrent multifocal osteomyelitis associated with pyoderma gangrenosum.

Sabrina AciernoFrancesca AngrisaniAchille MarinoRoberto Felice Caporali Rolando Cimaz Teresa Giani

Published in: International journal of rheumatic diseases (2022)

In this young patient pyoderma gangrenosum and CRMO showed a rapid and satisfactory response to canakinumab, although over time a decreased efficacy in controlling bone disease was observed.

Keyphrases

middle aged
case report
bone mineral density
soft tissue
body composition
drug induced
quantum dots